DBV Technologies | DBVT - Ebit



DBV Technologies reported $-41110000 in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Acadia Pharmaceuticals USD 32.37M 13.08M Jun/2025
Alnylam Pharmaceuticals USD 4.89M 13.19M Jun/2025
Amarin USD -16755000 707K Mar/2025
BioMarin Pharmaceutical USD 276.89M 52.99M Jun/2025
DBV Technologies USD -41110000 17.34M Jun/2025
Halozyme Therapeutics USD 202.44M 54.09M Jun/2025
Incyte USD 310.82M 27.18M Jun/2025
Insmed USD -253876000 5.74M Jun/2025
Ionis Pharmaceuticals USD 144.78M 290.78M Jun/2025
Neurocrine Biosciences USD 145.6M 121.9M Jun/2025
PTC Therapeutics USD -34858000 1.01B Jun/2025
Sarepta Therapeutics USD 115.58M 415.96M Jun/2025
Ultragenyx Pharmaceutical USD -193567000 50.63M Jun/2025
United Therapeutics USD 276.9M 105.9M Jun/2025